Spyre Therapeutics, Inc. logo SYRE - Spyre Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 12
HOLD 1
SELL 0
STRONG
SELL 0
| PRICE TARGET: $106.92 DETAILS
HIGH: $130.00
LOW: $49.00
MEDIAN: $117.50
CONSENSUS: $106.92
UPSIDE: 22.54%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: SYRE has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.